These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 3674053

  • 1. Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations.
    Falko JM, Parr JH, Simpson RN, Wynn V.
    Am J Med; 1987 Oct; 83(4):641-7. PubMed ID: 3674053
    [Abstract] [Full Text] [Related]

  • 2. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
    Watanabe N, Taniguchi T, Taketoh H, Kitagawa Y, Namura H, Yoneda N, Kurimoto Y, Yamada S, Ishikawa Y.
    Diabetes Care; 1999 Jan; 22(1):152-6. PubMed ID: 10333918
    [Abstract] [Full Text] [Related]

  • 3. Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects.
    Laakso M, Pyörälä K, Voutilainen E, Marniemi J.
    Am J Epidemiol; 1987 Apr; 125(4):611-21. PubMed ID: 3548333
    [Abstract] [Full Text] [Related]

  • 4. Influence of endogenous hyperinsulinism on high density lipoprotein2 level in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance.
    Jiao S, Kameda K, Matsuzawa Y, Kubo M, Nonaka K, Tarui S.
    Atherosclerosis; 1986 Jun; 60(3):279-86. PubMed ID: 3730047
    [Abstract] [Full Text] [Related]

  • 5. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM).
    Uddin F, Miah AK.
    Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):64-72. PubMed ID: 8815864
    [Abstract] [Full Text] [Related]

  • 6. Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study.
    Salomaa VV, Tuomilehto J, Jauhiainen M, Korhonen HJ, Stengård J, Uusitupa M, Pitkanen M, Penttila I.
    Diabetes Care; 1992 May; 15(5):657-65. PubMed ID: 1516486
    [Abstract] [Full Text] [Related]

  • 7. Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease.
    Bakogianni MC, Kalofoutis CA, Skenderi KI, Kalofoutis AT.
    J Diabetes Complications; 2001 May; 15(5):265-9. PubMed ID: 11522502
    [Abstract] [Full Text] [Related]

  • 8. Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus.
    Chen YD, Swami S, Skowronski R, Coulston A, Reaven GM.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):172-7. PubMed ID: 8421086
    [Abstract] [Full Text] [Related]

  • 9. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes.
    Laakso M, Pyörälä K.
    Metabolism; 1990 Feb; 39(2):117-22. PubMed ID: 2299984
    [Abstract] [Full Text] [Related]

  • 10. Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis.
    Laakso M, Barrett-Connor E.
    Arteriosclerosis; 1989 Feb; 9(5):665-72. PubMed ID: 2675810
    [Abstract] [Full Text] [Related]

  • 11. Plasma lipoproteins and incidence of non-insulin-dependent diabetes mellitus in Pima Indians: protective effect of HDL cholesterol in women.
    Fagot-Campagna A, Narayan KM, Hanson RL, Imperatore G, Howard BV, Nelson RG, Pettitt DJ, Knowler WC.
    Atherosclerosis; 1997 Jan 03; 128(1):113-9. PubMed ID: 9051204
    [Abstract] [Full Text] [Related]

  • 12. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK, Mohamed Ali V, Jain SK, Walji S, Yudkin JS.
    Diabet Med; 1996 Jan 03; 13(1):59-64. PubMed ID: 8741814
    [Abstract] [Full Text] [Related]

  • 13. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance.
    Laakso M, Sarlund H, Mykkänen L.
    Arteriosclerosis; 1990 Jan 03; 10(2):223-31. PubMed ID: 2180396
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
    Haffner SM, Agil A, Mykkanen L, Stern MP, Jialal I.
    Diabetes Care; 1995 May 03; 18(5):646-53. PubMed ID: 8586002
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma lipids and lipoproteins in diabetes: lessons from population-based studies.
    Laakso M, Pyörälä K.
    J Diabet Complications; 1990 May 03; 4(2):39-41. PubMed ID: 2145294
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
    al-Muhtaseb N, al-Yuosuf AR, Bajaj JS.
    Acta Diabetol Lat; 1991 May 03; 28(1):61-9. PubMed ID: 1862693
    [Abstract] [Full Text] [Related]

  • 20. Serum lipids, lipoproteins and macrovascular disease in non-insulin-dependent diabetics: a possible new approach to prevention.
    Seviour PW, Teal TK, Richmond W, Elkeles RS.
    Diabet Med; 1988 Mar 03; 5(2):166-71. PubMed ID: 2964984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.